The Signal in the Search: What Participant Patterns Reveal About Protocol Risk
Participant search patterns reveal protocol friction points before they become deviations — a new kind of quality signal for coordinators, CROs, and sponsors.
Site coordinators and CRO teams rarely get to see what participants go back to between visits, or how often.
In a clinical setting, participants are often at their most composed. They nod during the consent process. They genuinely want to be helpful. They may not have a question in the moment, but the reality of the protocol doesn't fully land until they're back home, trying to integrate a complex set of requirements into daily life.
At Clear Trials, we think the gap between what gets explained at the site and what gets practiced at home isn't empty space. It's filled with data.
Patterns, Not Confusion
When we look at participant engagement, we look for patterns of friction.
A single search for a dietary restriction is a sign of a diligent participant. A participant who returns to the same "prohibited medications" section three times in 48 hours is sending a different kind of signal. A participant who searches "travel reimbursement" three times in the days before a visit is telling us something about what's weighing on them before they ever set foot in the clinic.
These patterns are designed to offer a type of visibility the industry hasn't had before.
High-frequency returns to a specific protocol section identify what we think of as a friction point: a place where the requirements are heavy, ambiguous, or simply hard to hold onto between visits.
And when the same pattern shows up across a study's participants, the signal gets more interesting. If 30 percent of a cohort is repeatedly checking the same procedure window, that's not an individual misunderstanding. That's a protocol design question, and Clear Trials is designed to surface it while the study is running rather than in a post-study retrospective.
Comprehension Is a Compliance Metric
The industry has traditionally treated participant experience as a soft outcome. In practice, comprehension is a compliance metric, and the cost of getting it wrong is concrete.
Protocol deviations remain one of the most expensive and persistent problems in clinical research. They are among the most common triggers for FDA inspection warning letters, with violations potentially leading to enforcement action if not promptly corrected. A TransCelerate survey of sponsors, sites, and IRBs confirmed that current deviation management processes are complex, varied, and often too slow to identify important deviations before they've already occurred.
The comprehension gap feeds directly into this problem. Research suggests that among participants who dropped out of studies early, 35 percent reported that the informed consent was difficult to understand, compared to 16 percent of those who completed the trial. Only 64 percent of early dropouts said their questions were fully answered during the consent discussion, compared to 89 percent of completers.
A deviation caught during a site visit is a save. A deviation caught by a monitor weeks later is a Corrective and Preventive Action. And a deviation that traces back to a participant who was uncertain about a protocol requirement but never said so is, in many cases, preventable.
From Reactive to Proactive
The traditional model of clinical trial operations is retrospective. Something goes wrong, it gets documented, and then the team works backward to understand why.
Clear Trials is designed to create a different trigger point. When search patterns shift in the days before a visit, a coordinator has a window — not for a generic check-in call, but for a targeted conversation grounded in something specific:
"I saw there's been some activity around the fasting requirements ahead of Thursday. I wanted to reach out and walk through those steps with you so we're on the same page going in."
That's not surveillance. The participant chose to use the platform. Their engagement surfaces something the care team has not historically had access to: what participants are uncertain about, when they're uncertain about it, and where in the protocol that uncertainty lives.
Most retention problems start long before a participant officially drops out, with warning signs building up as a chain of unaddressed friction. Protocol deviations follow the same pattern. They don't usually begin at the site. They begin at home, in the space between what a participant remembers and what the protocol actually requires.
What It's Designed to Change
Most coordinators and CRO teams would expect a tool like this to reduce inbound participant calls. The larger opportunity is a window into participant engagement designed to help them intervene earlier, more specifically, and with more context than a coordinator has historically had before a visit.
The goal is less reactive triage, more proactive outreach, and a clearer sense of where to focus attention across a panel of enrolled participants.
For sponsors, the study-level view matters even more. Questions that cluster across a study's participants could surface protocol friction points before they become deviation patterns — a different kind of quality signal than anything available through traditional monitoring. Looking across studies, de-identified, is what we're building next.
Clear Trials is designed to give participants clarity, coordinators visibility, and sponsors earlier signal on the protocol friction that drives deviations and dropout.